SherpaBonds

Cencora Inc

14 bondsIndustrial🇺🇸 US
▶ Walk the curve
Outstanding
—
Avg yield
4.98%
14 of 14 priced
Active bonds
14
Currencies
USD
Countries
US

About Cencora Inc

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.

SOURCE: WIKIPEDIA →

Maturity ladder

Active bonds by year of maturity

2027
2
2029
2
2030
2
2031
1
2033
1
2034
1
2035
1
2036
1
2045
1
2047
1
2056
1

All bonds

IdentifierNameCouponMaturityCcyCountryPriceYieldAs of
US03073EAP07Cencora Inc 3.45% 12/20273.450%2027-12-15USD🇺🇸US98.524.41%2026-05-07
US03073EAV74Cencora Inc 4.63% 12/20274.630%2027-12-15USD🇺🇸US100.314.42%2026-05-07
US03073EBC84Cencora Inc 3.95% 02/20293.950%2029-02-13USD🇺🇸US98.514.53%2026-05-07
US03073EAW57Cencora Inc 4.85% 12/20294.850%2029-12-15USD🇺🇸US101.004.54%2026-05-07
US03073EAR62Cencora Inc 2.8% 05/20302.800%2030-05-15USD🇺🇸US93.314.64%2026-05-07
US03073EBB02Cencora Inc 4.25% 11/20304.250%2030-11-15USD🇺🇸US98.074.73%2026-05-07
US03073EAT29Cencora Inc 2.7% 03/20312.700%2031-03-15USD🇺🇸US91.714.72%2026-05-07
US03073EBD67Cencora Inc 4.6% 02/20334.600%2033-02-13USD🇺🇸US98.194.92%2026-05-07
US03073EAU91Cencora Inc 5.13% 02/20345.130%2034-02-15USD🇺🇸US100.215.09%2026-05-07
US03073EAY14Cencora Inc 5.15% 02/20355.150%2035-02-15USD🇺🇸US100.395.09%2026-05-07
US03073EBE41Cencora Inc 4.9% 02/20364.900%2036-02-13USD🇺🇸US97.615.21%2026-05-07
US03073EAN58Cencora Inc 4.25% 03/20454.250%2045-03-01USD🇺🇸US83.255.79%2026-05-07
US03073EAQ89Cencora Inc 4.3% 12/20474.300%2047-12-15USD🇺🇸US83.655.77%2026-05-07
US03073EBF16Cencora Inc 5.65% 02/20565.650%2056-02-13USD🇺🇸US98.075.88%2026-05-07
Currency mix
USD14 · 100%
Issuing countries
🇺🇸United StatesUS
Ratings
S&P
BBB+
Moody's
Baa1
14 of 14 bonds rated